Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage

Lancet Infect Dis. 2023 Feb;23(2):147-148. doi: 10.1016/S1473-3099(22)00831-3. Epub 2023 Jan 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Viral